0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Health Agencies Update |  January 23, 2013
Telaprevir Warning
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.22.
Original Contribution |  December 26, 2012
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer, MD; Bart J. Veldt, MD, PhD; Jordan J. Feld, MD, PhD; et al.
JAMA. 2012;308(24):2584-2593. doi:10.1001/jama.2012.144878.
Health Agencies Update |  November 28, 2012
Drugs and Liver Injury
Bridget M. Kuehn, MSJ
JAMA. 2012;308(20):2073. doi:10.1001/jama.2012.76683.
Preliminary Communication |  November 14, 2012 FREE
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu, MD, PhD, MPH; Yi-Ju Chen, MD, PhD; Hsiu J. Ho, PhD; et al.
JAMA. 2012;308(18):1906-1913. doi:10.1001/2012.jama.11975.
INCLUDES: , Supplemental Content
Editorial |  November 14, 2012
Does Antiviral Therapy Prevent Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Curative Liver Resection?
Anna S. F. Lok, MD
JAMA. 2012;308(18):1922-1924. doi:10.1001/jama.2012.12971.
Clinical Crossroads |  August 08, 2012
Management of Nonalcoholic Fatty Liver Disease:  A 60-Year-Old Man With Probable Nonalcoholic Fatty Liver Disease: Weight Reduction, Liver Biopsy, or Both?
Nezam H. Afdhal, MD
JAMA. 2012;308(6):608-616. doi:10.1001/jama.2012.8402.
INCLUDES: CME
Medical News and Perspectives |  May 23, 2012
Hepatitis Drug Reduces Effects of HIV Medications
Bridget M. Kuehn
JAMA. 2012;307(20):2138. doi:10.1001/jama.2012.5417.
Global Health |  May 16, 2012
Global Burden of Hepatitis E Virus
M. J. Friedrich
JAMA. 2012;307(19):2017. doi:10.1001/jama.2012.5081.
Viewpoint |  May 09, 2012
New Genetic Discoveries and Treatment for Hepatitis C
Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH
JAMA. 2012;307(18):1921-1922. doi:10.1001/jama.2012.3516.
Health Agencies Update |  March 28, 2012
HIV, Hepatitis Drug Interactions
Bridget M. Kuehn
JAMA. 2012;307(12):1243. doi:10.1001/jama.2012.332.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 8, 2013
Long-term Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases
Paul J. Karanicolas, MD, PhD; William R. Jarnagin, MD; Mithat Gonen, PhD; et al.
JAMA Surgery
Invited Critique  |  May 8, 2013
To Ablate or Not to Ablate?: That Is the Question:  Comment on “Tumor Ablation Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases”
Karen L. Sherman, MD; David J. Bentrem, MD, MS
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  April 22, 2013
Bizarre and Wide QRS After Liver Transplant
Colleen J. Johnson, MD, MS; Melvin A. Scheinman, MD; Mintu P. Turakhia, MD, MAS
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  April 22, 2013
Bizarre and Wide QRS After Liver Transplant—Discussion
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems